News|Ultrasound Imaging| June 28, 2022

Mindray expands its portfolio with a new innovative, dedicated OB/GYN ultrasound machine, the Imagyn I9

Mindray Imagyn I9 Ultrasound System

Mindray Imagyn I9 Ultrasound System


June 28, 2022 —Mindray, a global leader and developer of healthcare technologies and solutions forultrasound,病人监护, andanesthesia, announced the launch of a new ultrasound product to address the unique demands of busyOB/GYNpractices — the Imagyn I9 Ultrasound Machine. TheImagyn I9 Ultrasound Systemis Mindray's first dedicated OB/GYN product slated to meet the rigorous demands of OB/GYN practices. The new system has unique design elements that focus on usability and ergonomics within the OB/GYN space, including elevated transducer ports, a fully free-floating user interface, and customizableE-Inkkeys.

Powered by Mindray's revolutionaryZONE Sonography Technology+(ZST+) and leveraging AI-enhanced technologies, the Imagyn I9 Ultrasound System uses auto clinical scenario identification and automation at every point, from imaging optimization to planes acquisition, quantification, and creating an automated workflow. The Imagyn I9Ultrasound Systemprovides a full-stack smart solution for efficient women's health, covering wide-ranging applications from pre-pregnancy to obstetric to post-partum.

"As we continue to strengthen our position in women's health, the addition of the Imagyn I9 Ultrasound Machine shows our dedication to advance medical technologies to make healthcare more accessible," said Wayne Quinn, President of Mindray North America. Quinn continued, "We are pleased to introduce the first dedicated OB/GYN ultrasound system powered by our revolutionary ZST+. This milestone will tremendously impact women's health clinicians and empower them to deliver high-quality care with peace of mind."

Mindray develops meaningful ultrasound solutions to help clinicians provide timely answers and elevate patient care. Mindray's innovative, accessible ultrasound machines deliver exceptional image quality with a suite of artificial intelligence (AI) enhanced technologies to help clinicians improve reproducibility, optimize productivity, and achieve consistency. The Imagyn I9 Ultrasound System features innovative design elements such as an intelligent iConsole control panel, a 2-hour continuous scanning battery, and quiet operation. Breaking the mold of conventional ultrasound systems and bringing ease-of-use and ergonomics into the limelight, the Imagyn I9 Ultrasound System provides an entirely new experience driven by innovation.

Imagyn I9 Ultrasound System Advanced Technologies Highlights:

• Sound Speed Compensation (SSC): Automatically detects and analyzes differenttissue characteristics确定并应用改善图像质量所需的最佳声速。这种独特的一键式智能算法提高了横向、空间和对比度分辨率以及深度成像。

• Glazing Flow: Provides optimal visualization by intuitively and dynamically displaying a 3D effect to blood flow with high definition and clarity, especially for tiny and overlapping vessels. This technology can also be applied post-processing.

• Smart Face: Delivers a fast and intelligent optimization for fetal face with a simple one-touch operation. It can immediately remove occlusions such as cord, placenta, uterus, and extremities in the volume data to generate an optimal view of the fetal face, reducing the need for time-consuming manual adjustments.

• Smart Planes CNS: Provides a robust and user-friendly solution to automatically detect planes and calculate frequently used measurements of thecentral nervous system(CNS) in fetal brain examinations with one-touch. By automating these measurements, exam times decrease, allowing more time to focus on anatomy.

The Imagyn I9 Ultrasound is available immediately through Mindray's trusted partners. Mindray's ultrasound solutions, including the Imagyn I9, command the industry's best investment protection and total cost of ownership with a standard 5-year warranty and Mindray's exclusiveLiving Technology™ promise that provides customers with easily upgradable software enhancements. Through innovative solutions like the Imagyn I9, Mindray continues to drive its mission forward, advancing medical technologies to make healthcare more accessible.

For more information:www.mindray.com

Related Content

The SpeedBird and Concorde device platforms are based on TransMed7’s patented Zero5 work element composed of a fused, single element constructed from 3 hypotubes, laser cut and welded to form articulable twin cutter blades at the end of a rotating open tube
News|Ultrasound Women's Health

August 10, 2022 — TransMed7, LLC announced that the first clinical cases of the final commercial production version of ...

TimeAugust 10, 2022
arrow
Mindray solidifies its position as an industry innovator and leader in the POCUS market with the debut of the newest edition to the TE Series Ultrasound Family, the TE X
News|Point-of-Care Ultrasound (POCUS)

August 10, 2022 — Mindray North America, a global leader and developer of healthcare technologies and solutions for ...

TimeAugust 10, 2022
arrow
Portable digital radiography brought to remote locations in Nepal
Feature|Radiology Business| By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

TimeAugust 01, 2022
arrow
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology
News|RSNA

July 29, 2022 — The Radiological Society of North America (RSNA), in collaboration with the American Society of ...

TimeJuly 29, 2022
arrow
for patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis (DBT), biopsy of all areas may be warranted, given the variation of pathologic diagnoses across AD in individual patients
News|2022世界杯篮球预选赛赛程

July 28, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), for patients with multiple architectural ...

TimeJuly 28, 2022
arrow
The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, and how often to screen
News|Mammography

2022年7月28日-国家综合癌症网络(NCCN)发布了新的患者NCCN指南:乳房……

TimeJuly 28, 2022
arrow
Viz.ai是一家领先的人工智能疾病检测和智能护理协调平台,日前宣布将与Hyperfine公司合作,Hyperfine公司是首个获得fda批准的医疗点磁共振成像(MRI)设备Swoop的创造者。
News|Magnetic Resonance Imaging (MRI)

July 27, 2022 — Viz.ai, a leading AI-powered disease detection and intelligent care coordination platform, announced it ...

TimeJuly 27, 2022
arrow
Aidoc artificial intelligence
News|Artificial Intelligence

July 26, 2022 — Aidoc, a leading provider of AI healthcare solutions, today announced a partnership with UofL Health, a ...

TimeJuly 26, 2022
arrow
The Imagio Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using non-invasive opto-acoustic/ultrasound (OA/US) technology to provide information on breast lesions in real time, helping providers to characterize and differentiate masses that may — or may not — require more invasive diagnostic evaluation.
News|2022世界杯篮球预选赛赛程

July 26, 2022 — Seno Medical’s Imagio Breast Imaging System, a revolutionary new modality in breast imaging, has ...

TimeJuly 26, 2022
arrow
The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information system market is expected to grow from $2.59 billion in 2022 to $5.48 billion by 2032
News|Oncology Information Management Systems (OIMS)

July 26, 2022 — The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information ...

TimeJuly 26, 2022
arrow
Subscribe Now